DOI: https://doi.org/10.22263/2312-4156.2021.3.46
Bondarenko V.M., Pimanov S.I., Makarenko E.V.
Validization of the most informative techniques for ultrasound diagnostics of visceral obesity
Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus
Vestnik VGMU. 2021;20(3):46-54.
Abstract.
Objectives. To validate the ultrasound method of diagnosing visceral obesity in patients with cardiovascular diseases and metabolic syndrome.
Material and methods. The study involved 115 people aged from 19 to 60 years, who represented a continuous random sample (examination sample). The diagnostic efficacy of shear wave ultrasound elastography of the lower perirenal visceral adipose tissue (VAT) was evaluated in 59 patients. Ultrasound examination was performed on the Logiq E9 ultrasound machine (GE Healthcare, USA); convex 3.5 MHz and linear 10.0 MHz sensors were used.
Results. To assess visceral obesity, the following measurements are recommended: the area of the lower perirenal adipose tissue (AT), the distance between the surface of the rectus abdominis muscle and the anterior wall of the aorta, the thickness of the epicardial and pericardial AT, as well as the elastography of the lower part of the perirenal AT. According to the results of the performed validation of ultrasound VAT measuring techniques, the accuracy of visceral obesity diagnosing in patients with arterial hypertension with the use of the boundary values of the lower part perirenal AT area made up 87.8%. The accuracy of visceral obesity diagnosing in patients with coronary heart disease, taking into account the boundary values of the epicardial AT thickness equalled 86.2%, and pericardial AT thickness amounted to 95.4%. Diagnosing of visceral obesity in patients with metabolic syndrome by measuring four ultrasound parameters (area of the lower part of perirenal AT, thickness of intraabdominal AT, epicardial and pericardial VAT) was carried out with an accuracy of 86.1%. Elastic modulus determination during elastography of the lower part of the perirenal AT using the boundary values, established for patients with metabolic syndrome, was performed with an accuracy of 91.5%.
Key words: ultrasound investigation, visceral adipose tissue, reproducibility, metabolic syndrome, arterial hypertension, ischemic heart disease, validization.
References
1. Goyal A, Nimmakayala KR, Zonszein J. Is there a paradox in obesity? Cardiol Rev. 2014 Jul-Aug;22(4):163-70. doi: http://dx.doi.org/10.1097/CRD.0000000000000004.
2. Blüher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab. 2013 Apr;27(2):163-77. doi: http://dx.doi.org/10.1016/j.beem.2013.02.005
3. Blüher M. Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):341-6. doi: http://dx.doi.org/10.1097/MED.0b013e328357f0a3
4. Piché M-E, Poirier P, Lemieux I, Després J-P. Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update. Prog Cardiovasc Dis. 2018 Jul-Aug;61(2):103-113. doi: http://dx.doi.org/10.1016/j.pcad.2018.06.004
5. Klöting N, Fasshauer M, Dietrich A, Kovacs P, Schön MR, Kern M, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab. 2010 Sep;299(3):E506-15. doi: http://dx.doi.org/10.1152/ajpendo.00586.2009
6. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008 Aug;168(15):1617-24. doi: http://dx.doi.org/10.1001/archinte.168.15.1617
7. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu C-Y, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation. 2007 Jul;116(1):39-48. doi: http://dx.doi.org/10.1161/CIRCULATIONAHA.106.675355
8. Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation. 2011 Dec;124(24):e837-41. doi: http://dx.doi.org/10.1161/CIRCULATIONAHA.111.077602
9. Vlachos IS, Hatziioannou A, Perelas A, Perrea DN. Sonographic assessment of regional adiposity. AJR Am J Roentgenol. 2007 Dec;189(6):1545-53. doi: http://dx.doi.org/10.2214/AJR.07.2366
10. Pimanov SI, Bondarenko VM, Makarenko EV. Selection of the optimal ultrasound technique for measuring the amount of visceral adipose tissue. Problemy Zdorov'ia Ekologii. 2019;62(4):105-13. (In Russ.)
11. Pimanov SI, Bondarenko VM, Marchuk VP, Mikhailova NA, Sapego AL, Makarenko EV. Evaluation of visceral adipose tissue measurement by ultrasonography and computed tomography. Ul'trazvukovaia Funktsion Diagnostika. 2016;(4):59-72. (In Russ.)
12. Pimanov S, Bondarenko V, Makarenko E. Visceral fat in different locations assessed by ultrasound: Correlation with computed tomography and cut-off values in patients with metabolic syndrome. Clin Obes. 2020;10(6):e12404. doi: http://dx.doi.org/10.22263/2312-4156.2019.3.81
13. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009 Oct;120(16):1640-5. doi: http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192644
14. Pimanov SI, Bondarenko VM, Makarenko EV. Two-dimensional shear wave elastography of peri-renal visceral adipose tissue in patients with metabolic syndrome. Vestn VGMU. 2019;18(3):81-8. (In Russ.)
15. Korneenkov AA, Riazantcev SV, Viazemskaia EE. Calculation and Interpretation of Indicators of Informativeness of Diagnostic Medical Technologies. Med Sovet. 2019;(20):45-51. (In Russ.)
16. Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007 May;96(5):644-7. doi: http://dx.doi.org/10.1111/j.1651-2227.2006.00178.x
17. Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O. Localization of fat depots and cardiovascular risk. Lipids Health Dis. 2018 Sep;17(1):218. doi: http://dx.doi.org/10.1186/s12944-018-0856-8
18. Snijder MB, Visser M, Dekker JM, Goodpaster BH, Harris TB, Kritchevsky SB, et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The health ABC study. Diabetologia. 2005 Feb;48(2):301-8. doi: http://dx.doi.org/10.1007/s00125-004-1637-7
19. Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012 Sep;308(11):1150-9. doi: http://dx.doi.org/10.1001/2012.jama.11132
20. Bays HE. Adiposopathy, diabetes mellitus, and primary prevention of atherosclerotic coronary artery disease: treating «sick fat» through improving fat function with antidiabetes therapies. Am J Cardiol. 2012 Nov;110(9 Suppl):4B-12B. doi: http://dx.doi.org/10.1016/j.amjcard.2012.08.029
21. Lim S. Ectopic fat assessment focusing on cardiometabolic and renal risk. Endocrinol Metab (Seoul). 2014 Mar;29(1):1-4. doi: http://dx.doi.org/10.3803/EnM.2014.29.1.1
22. Gong W, Ren H, Tong H, Shen X, Luo J, Chen S, et al. A comparison of ultrasound and magnetic resonance imaging to assess visceral fat in the metabolic syndrome. Asia Pac J Clin Nutr. 2007;16 Suppl 1:339-45.
23. Bellan M, Menegatti M, Ferrari C, Carnevale GP, Pirisi SM. Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice. Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):610-7. doi: http://dx.doi.org/10.1016/j.numecd.2018.01.006
Information about authors:
Bondarenko V.M. – senior lecturer of the Chair of Hospital Surgery with the course of the Faculty for Advanced Training & Retraining, Vitebsk State Order of Peoples’ Friendship Medical University;
Pimanov S.I. – Doctor of Medical Sciences, professor, head of the Chair of Internal Diseases & Ultrasound Diagnostics of the Faculty for Advanced Training & Retraining, Vitebsk State Order of Peoples’ Friendship Medical University;
Makarenko E.V. – Doctor of Medical Sciences, professor of the Chair of Internal Diseases & Ultrasound Diagnostics of the Faculty for Advanced Training & Retraining, Vitebsk State Order of Peoples’ Friendship Medical University.
Correspondence address: Republic of Belarus, 210009, Vitebsk, 27 Frunze ave., Vitebsk State Order of Peoples’ Friendship Medical University, Chair of Hospital Surgery with the course of the Faculty for Advanced Training & Retraining. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Vladimir M. Bondarenko.
